Literature DB >> 27791122

FASN regulates cellular response to genotoxic treatments by increasing PARP-1 expression and DNA repair activity via NF-κB and SP1.

Xi Wu1, Zizheng Dong1, Chao J Wang1, Lincoln James Barlow1, Valerie Fako1, Moises A Serrano2, Yue Zou2, Jing-Yuan Liu1,3, Jian-Ting Zhang4,5.   

Abstract

Fatty acid synthase (FASN), the sole cytosolic mammalian enzyme for de novo lipid synthesis, is crucial for cancer cell survival and associates with poor prognosis. FASN overexpression has been found to cause resistance to genotoxic insults. Here we tested the hypothesis that FASN regulates DNA repair to facilitate survival against genotoxic insults and found that FASN suppresses NF-κB but increases specificity protein 1 (SP1) expression. NF-κB and SP1 bind to a composite element in the poly(ADP-ribose) polymerase 1 (PARP-1) promoter in a mutually exclusive manner and regulate PARP-1 expression. Up-regulation of PARP-1 by FASN in turn increases Ku protein recruitment and DNA repair. Furthermore, lipid deprivation suppresses SP1 expression, which is able to be rescued by palmitate supplementation. However, lipid deprivation or palmitate supplementation has no effect on NF-κB expression. Thus, FASN may regulate NF-κB and SP1 expression using different mechanisms. Altogether, we conclude that FASN regulates cellular response against genotoxic insults by up-regulating PARP-1 and DNA repair via NF-κB and SP1.

Entities:  

Keywords:  DNA repair; drug resistance; fatty acid synthase; radiation resistance; transcription regulation

Year:  2016        PMID: 27791122      PMCID: PMC5111708          DOI: 10.1073/pnas.1609934113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  57 in total

1.  Nuclear factor 1 interferes with Sp1 binding through a composite element on the rat poly(ADP-ribose) polymerase promoter to modulate its activity in vitro.

Authors:  M A Laniel; G G Poirier; S L Guerin
Journal:  J Biol Chem       Date:  2001-03-07       Impact factor: 5.157

2.  Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase.

Authors:  T Ruscetti; B E Lehnert; J Halbrook; H Le Trong; M F Hoekstra; D J Chen; S R Peterson
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

Review 3.  On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

Authors:  Xin Luo; W Lee Kraus
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

4.  Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker.

Authors:  Hailan Liu; Jing-Yuan Liu; Xi Wu; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2010-07-18

5.  EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

Authors:  Zizheng Dong; Jian-Ting Zhang
Journal:  Mol Biol Cell       Date:  2003-05-29       Impact factor: 4.138

6.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

7.  Increased expression of DNA-dependent protein kinase confers resistance to adriamycin.

Authors:  H Shen; M Schultz; G D Kruh; K D Tew
Journal:  Biochim Biophys Acta       Date:  1998-07-23

8.  Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.

Authors:  Ivan Ahel; Dragana Ahel; Takahiro Matsusaka; Allison J Clark; Jonathon Pines; Simon J Boulton; Stephen C West
Journal:  Nature       Date:  2008-01-03       Impact factor: 49.962

9.  APLF promotes the assembly and activity of non-homologous end joining protein complexes.

Authors:  Gabrielle J Grundy; Stuart L Rulten; Zhihong Zeng; Raquel Arribas-Bosacoma; Natasha Iles; Katie Manley; Antony Oliver; Keith W Caldecott
Journal:  EMBO J       Date:  2012-11-23       Impact factor: 11.598

Review 10.  Molecular mechanisms of fatty acid synthase (FASN)-mediated resistance to anti-cancer treatments.

Authors:  Xi Wu; Li Qin; Valerie Fako; Jian-Ting Zhang
Journal:  Adv Biol Regul       Date:  2013-09-15
View more
  28 in total

1.  14-3-3σ Contributes to Radioresistance By Regulating DNA Repair and Cell Cycle via PARP1 and CHK2.

Authors:  Yifan Chen; Zhaomin Li; Zizheng Dong; Jenny Beebe; Ke Yang; Liwu Fu; Jian-Ting Zhang
Journal:  Mol Cancer Res       Date:  2017-01-13       Impact factor: 5.852

2.  A PET imaging agent for evaluating PARP-1 expression in ovarian cancer.

Authors:  Mehran Makvandi; Austin Pantel; Lauren Schwartz; Erin Schubert; Kuiying Xu; Chia-Ju Hsieh; Catherine Hou; Hyoung Kim; Chi-Chang Weng; Harrison Winters; Robert Doot; Michael D Farwell; Daniel A Pryma; Roger A Greenberg; David A Mankoff; Fiona Simpkins; Robert H Mach; Lilie L Lin
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

3.  Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models.

Authors:  Mehran Makvandi; Hwan Lee; Laura N Puentes; Sean W Reilly; Komal S Rathi; Chi-Chang Weng; Ho Sze Chan; Catherine Hou; Pichai Raman; Daniel Martinez; Kuiying Xu; Sean D Carlin; Roger A Greenberg; Bruce R Pawel; Robert H Mach; John M Maris; Daniel A Pryma
Journal:  Mol Cancer Ther       Date:  2019-05-09       Impact factor: 6.261

4.  Specific protein 1 inhibitor mithramycin A protects cardiomyocytes from myocardial infarction via interacting with PARP.

Authors:  Haihua Geng; Yamin Su; Rong Huang; Mengkang Fan; Xiaofei Li; Xiaochen Lu; Hongzhuan Sheng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-12       Impact factor: 2.416

Review 5.  Pleiotropic role of PARP1: an overview.

Authors:  Vikas Kumar; Anurag Kumar; Khursheed Ul Islam Mir; Vandana Yadav; Shyam Singh Chauhan
Journal:  3 Biotech       Date:  2021-12-04       Impact factor: 2.406

Review 6.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

7.  Applying genome-wide CRISPR to identify known and novel genes and pathways that modulate formaldehyde toxicity.

Authors:  Yun Zhao; Linqing Wei; Abderrahmane Tagmount; Alex Loguinov; Amin Sobh; Alan Hubbard; Cliona M McHale; Christopher J Chang; Chris D Vulpe; Luoping Zhang
Journal:  Chemosphere       Date:  2020-10-22       Impact factor: 7.086

Review 8.  The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks.

Authors:  Máté A Demény; László Virág
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

9.  Proton pump inhibitors suppress DNA damage repair and sensitize treatment resistance in breast cancer by targeting fatty acid synthase.

Authors:  Chao J Wang; Deren Li; Jacob A Danielson; Evan H Zhang; Zizheng Dong; Kathy D Miller; Lang Li; Jian-Ting Zhang; Jing-Yuan Liu
Journal:  Cancer Lett       Date:  2021-04-01       Impact factor: 9.756

Review 10.  Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.

Authors:  Yueqi Zhang; Hongbing Wang; Hua Xiao
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.